Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Multicentre Randomised Phase II Study of AZD1775 Plus Chemotherapy Versus Chemotherapy Alone in Patients with Platinum-Resistant TP53-Mutated Epithelial Ovarian, Fallopian Tube, or Primary...
Sponsored by SCRI Development Innovations, LLC
Active
$295.3K Funding
1 People
External
Related Topics
ovarian cancer,
chemotherapy,
tp53 mutation,
clinical trial,
drug combination
People
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor
